Search research articles
Contact Us
Filters
Showing results (41-50 of 90) with videos related to
Page
of 9
Sort By:
Annals of Hematology
|
March 12, 2026
Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis
Tamir Shragai, Muhammad Ganayem, Yael C Cohen, et al.
Haematologica
|
March 31, 2022
Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma
Ortal Harush, Nathalie Asherie, Shlomit Kfir-Erenfeld, et al.
American Journal of Hematology
|
November 3, 2016
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy
Adir Shaulov, Chezi Ganzel, Noam Benyamini, et al.
Acta Haematologica
|
October 2, 2024
Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the Literature
Eyal Lebel, Vladimir Vainstein, Paolo Milani, et al.
Acta Haematologica
|
August 7, 2022
Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid Leukemia
Boaz Nachmias, Svetlana Krichevsky, Dvora Filon, et al.
Haematologica
|
June 29, 2023
Amyloidogenic light chains impair plasma cell survival
Marjorie Pick, Eyal Lebel, Sharona Elgavish, et al.
European Journal of Haematology
|
February 18, 2018
Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis
Marjorie Pick, Vladimir Vainstein, Neta Goldschmidt, et al.
European Journal of Haematology
|
December 24, 2022
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity-induced rash in patients with multiple myeloma
Oded Shamriz, Elchanan Parnasa, Limor Rubin, et al.
Cancers
|
March 29, 2023
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World Study
Eyal Lebel, Efstathios Kastritis, Giovanni Palladini, et al.
Leukemia & Lymphoma
|
February 15, 2014
Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia
Jacob Vine, Sara Bar Cohen, Rosa Ruchlemer, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 90) with videos related to
Sort By:
Page
of 9
Annals of Hematology
|
March 12, 2026
Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis
Tamir Shragai, Muhammad Ganayem, Yael C Cohen, et al.
Haematologica
|
March 31, 2022
Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma
Ortal Harush, Nathalie Asherie, Shlomit Kfir-Erenfeld, et al.
American Journal of Hematology
|
November 3, 2016
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy
Adir Shaulov, Chezi Ganzel, Noam Benyamini, et al.
Acta Haematologica
|
October 2, 2024
Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the Literature
Eyal Lebel, Vladimir Vainstein, Paolo Milani, et al.
Acta Haematologica
|
August 7, 2022
Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid Leukemia
Boaz Nachmias, Svetlana Krichevsky, Dvora Filon, et al.
Haematologica
|
June 29, 2023
Amyloidogenic light chains impair plasma cell survival
Marjorie Pick, Eyal Lebel, Sharona Elgavish, et al.
European Journal of Haematology
|
February 18, 2018
Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis
Marjorie Pick, Vladimir Vainstein, Neta Goldschmidt, et al.
European Journal of Haematology
|
December 24, 2022
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity-induced rash in patients with multiple myeloma
Oded Shamriz, Elchanan Parnasa, Limor Rubin, et al.
Cancers
|
March 29, 2023
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World Study
Eyal Lebel, Efstathios Kastritis, Giovanni Palladini, et al.
Leukemia & Lymphoma
|
February 15, 2014
Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia
Jacob Vine, Sara Bar Cohen, Rosa Ruchlemer, et al.
Page
of 9